TCTMD

AccessClosure Launches the Next-Generation Mynx Ace™ Vascular Closure Device at Annual ACC Meeting

Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...
TCTMD

AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device

Mountain View, California – AccessClosure, Inc., the U.S. market leader in extravascular closure devices, announced today the launch of its next generation product, the Mynx Cadence Vascular Closure ...
Pharm Exec

FDA Approves Cordis’ Vascular Closure Device for Cardiac Ablation Procedures

Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures. The FDA ...
FOX8 Cleveland

Cordis receives FDA approval for MYNX CONTROL™ VENOUS Vascular Closure Device

Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...